These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15467736)

  • 21. The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes.
    Parrado A; Robledo M; Moya-Quiles MR; Marín LA; Chomienne C; Padua RA; Alvarez-López MR
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1898-903. PubMed ID: 14769944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.
    Wong CW; Privalsky ML
    J Biol Chem; 1998 Oct; 273(42):27695-702. PubMed ID: 9765306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
    Choi WI; Yoon JH; Kim MY; Koh DI; Licht JD; Kim K; Hur MW
    J Biol Chem; 2014 Jul; 289(27):18641-56. PubMed ID: 24821728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
    Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
    Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells.
    Quaranta MT; Spinello I; Testa U; Mariani G; Diverio D; Foà R; Peschle C; Labbaye C
    Oncogene; 2006 Jan; 25(3):399-408. PubMed ID: 16158049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
    Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
    J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of PLZF in melanoma progression.
    Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
    Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein.
    Tsuzuki S; Enver T
    Blood; 2002 May; 99(9):3404-10. PubMed ID: 11964310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Krüppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein.
    Medugno L; Florio F; De Cegli R; Grosso M; Lupo A; Costanzo P; Izzo P
    Gene; 2005 Oct; 359():35-43. PubMed ID: 16150558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.
    Girard N; Tremblay M; Humbert M; Grondin B; Haman A; Labrecque J; Chen B; Chen Z; Chen SJ; Hoang T
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13522-7. PubMed ID: 23898169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
    Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
    Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements.
    Fujimoto K; Hamaguchi H; Hashiba T; Nakamura T; Kawamoto T; Sato F; Noshiro M; Bhawal UK; Suardita K; Kato Y
    Int J Mol Med; 2007 Jun; 19(6):925-32. PubMed ID: 17487425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein.
    Labbaye C; Quaranta MT; Pagliuca A; Militi S; Licht JD; Testa U; Peschle C
    Oncogene; 2002 Sep; 21(43):6669-79. PubMed ID: 12242665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of Hoxb2 by APL-associated PLZF protein.
    Ivins S; Pemberton K; Guidez F; Howell L; Krumlauf R; Zelent A
    Oncogene; 2003 Jun; 22(24):3685-97. PubMed ID: 12802276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells.
    Eshel R; Ben-Zaken O; Vainas O; Nadir Y; Minucci S; Polliack A; Naparstek E; Vlodavsky I; Katz BZ
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1115-22. PubMed ID: 16112651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
    Rho SB; Park YG; Park K; Lee SH; Lee JH
    FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI; Chang WJ; Cho SG; Kim IY
    J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.